Literature DB >> 22751635

Renal denervation to treat resistant hypertension: Guarded optimism.

George Thomas1, Mehdi H Shishehbor, Emmanuel L Bravo, Joseph V Nally.   

Abstract

Renal sympathetic denervation has shown promise in treating hypertension resistant to drug therapy. This procedure lowers blood pressure via targeted attenuation of renal sympathetic tone, and it has a favorable safety profile. But although there is reason for cautious optimism, we should keep in mind that the mechanisms of hypertension are complex and multifactorial, and further study of this novel therapy and its long-term effects is needed.

Entities:  

Mesh:

Year:  2012        PMID: 22751635     DOI: 10.3949/ccjm.79a.12040

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  6 in total

Review 1.  A perspective on sympathetic renal denervation in chronic congestive heart failure.

Authors:  Raef Madanieh; Mohammed El-Hunjul; Hassan Alkhawam; Constantine E Kosmas; Abed Madanieh; Timothy J Vittorio
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

2.  Increased sympathetic drive during the onset of hypertension in conscious Cyp1a1-Ren2 rats.

Authors:  Su Young Han; Emily Gray; Gillian Hughes; Colin H Brown; Daryl O Schwenke
Journal:  Pflugers Arch       Date:  2013-08-25       Impact factor: 3.657

3.  Profound sustained hypotension following renal denervation: a dramatic success?

Authors:  Ganiga Srinivasaiah Sridhar; Timothy Watson; Chee Kok Han; Wan Azman Wan Ahmad
Journal:  Arq Bras Cardiol       Date:  2015-08       Impact factor: 2.000

Review 4.  Catheter-based renal denervation for treatment of resistant hypertension.

Authors:  Emine Hatipoglu; Albert Ferro
Journal:  JRSM Cardiovasc Dis       Date:  2013-05-15

5.  Percutaneous renal sympathetic denervation for the treatment of resistant hypertension with heart failure: first experience in Korea.

Authors:  Jeong Hoon Yang; Seung-Hyuk Choi; Hyeon-Cheol Gwon
Journal:  J Korean Med Sci       Date:  2013-06-03       Impact factor: 2.153

Review 6.  Renal denervation for treating resistant hypertension: current evidence and future insights from a global perspective.

Authors:  Y Castro Torres; Richard E Katholi
Journal:  Int J Hypertens       Date:  2013-11-27       Impact factor: 2.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.